Supplement encyclopedia

CURCUMINOIDS

Curcuminoids are a group of related turmeric compounds included in some extracts and supplements.

Check the conclusions and examine the sources before choosing a supplement.

Main conclusion

What they may offer

  • In a small study in moderately active adults, a curcuminoid mixture taken for five days did not clearly reduce total muscle soreness over the 72 hours after unfamiliar downhill running.
  • Curcugen may reduce overall digestive discomfort in adults with these complaints: over eight weeks, its score decreased more than with placebo.
  • In healthy women aged 18–40, after 60 days of WDTE60N, skin hydration increased and water loss through the skin decreased according to instrumental measurements. The study used 250 mg of this extract daily, containing 150 mg of a curcuminoid mixture.
  • An instrument measured the intensity of a skin spot: the score decreased by 2.28% versus 0.31% with placebo. Measured skin gloss also increased.

[1] [2] [3]

What was studied

  • One trial assessed muscle soreness after unfamiliar running, while another assessed an overall digestive symptom scale in adults.
  • Instrumental skin measures, including hydration and water loss, were assessed separately in healthy women.

[1] [2] [3]

Which forms were considered

  • Curcuminoids are a mixture of curcumin and related substances; the amounts of individual components depend on the product.
  • The studies used different compositions: a colloidal mixture, Curcugen with essential oils, and the water-dispersible extract WDTE60N.

[1] [2] [3] [4]

How to obtain them from food

  • Curcuminoids are obtained from turmeric: the ground spice and rhizome are added to dishes and curry blends. The amount of the mixture depends on the product’s composition and the recipe.
  • In an analysis of 13 commercial powders, the proportion of one component, curcumin, ranged from 0.057% to 2.06% by mass. This helps explain differences between products but does not specify the total content of all curcuminoids.

[1] [2] [3]

Effects and studied questions

How to read the certainty scale 1–4

Certainty is rated separately for each outcome. 1 is very low, 2 is low, 3 is moderate and 4 is high.

Goal or questionResultConfidenceStudiesPopulation studiedKey sources
Area under the soreness curveAfter unfamiliar downhill running, no clear difference in total soreness over 72 hours was found.44 moderately active adults; crossover comparison of 300 mg of a colloidal product containing 90 mg of curcuminoids versus placebo for 5 days and unfamiliar downhill running; the primary soreness AUC over 72 h did not differ convincingly. Secondary recovery from peak to 72 h −7.9 percentage points (SE 3.6), p=0.0346.
1/4 Very lowPrecision of the estimate: Small samples, wide intervals, multiple outcomes or unclear clinical significance. Consistency of results: Differences in results and compositions, or unknown reproducibility in a single trial. Applicability to the stated group: The formulation, clinical population or surrogate limits extrapolation to the entire class of mixtures and healthy people. Possible publication bias: Insufficient data for a separate downgrade; absence of bias has not been demonstrated. Study methods: Limitations of small trials, selective measurement, missing data or incomplete independent verification of the protocol.
11 trialA randomized, placebo-controlled, crossover clinical trial to evaluate the effect of a turmeric formulation on muscle soreness and function recovery in moderately active adults ↗44 moderately active adults
  1. A randomized, placebo-controlled, crossover clinical trial to evaluate the effect of a turmeric formulation on muscle soreness and function recovery in moderately active adults ↗
Overall GSRSOver 8 weeks, Curcugen reduced the overall digestive symptom score more than placebo.2.91→2.10 versus 2.65→2.18, interaction p=0.021, ES 0.57.
2/4 LowPrecision of the estimate: The CI of the difference was not extracted. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: The measurement directly addresses the specified narrow PICO. Possible publication bias: No specific data for a separate downgrade. Study methods: One small sponsored trial, 77 of 79 provided data.
11 trialEfficacy of a curcumin extract (Curcugen) on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomised, double-blind, placebo-controlled study ↗79 adults with self-reported gastrointestinal complaints, 77 included in the self-report analysis
  1. Efficacy of a curcumin extract (Curcugen) on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomised, double-blind, placebo-controlled study ↗
MoistureMeterSC hydrationIn the WDTE60N study, the instrumental skin hydration measure increased compared with placebo.19.31→24.47 versus 19.46→17.27 arbitrary units, raw contrast +7.35, p=0.001.
1/4 Very lowPrecision of the estimate: Uncertain effect size for this outcome. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: An instrumental measure; consumer relevance has not been established. Possible publication bias: No specific data for a separate downgrade. Study methods: Many outcomes, a sponsor and completer analysis.
11 trialEfficacy and Safety of an Oral Low-Dose Water-Dispersible Turmeric Extract Capsule on Facial Skin Health in Healthy Women: A Randomized, Double-Blind, Placebo-Controlled Trial ↗96 healthy women aged 18–40 randomized, 90 completed
  1. Efficacy and Safety of an Oral Low-Dose Water-Dispersible Turmeric Extract Capsule on Facial Skin Health in Healthy Women: A Randomized, Double-Blind, Placebo-Controlled Trial ↗

The study count refers to the cited source. Reviews with overlapping trials and outcomes from one study are not added together.

Daily intake requirements and upper limits

Intake and studied regimens
ContextInformation
After exercise300 mg of product containing 90 mg of curcuminoids: 5 days of supplementation, follow-up after exercise — 72 hours.
Digestive complaintsCurcugen: 500 mg of extract daily, about 250 mg of curcuminoids, for 8 weeks. The composition included 50% curcuminoids and 1.5% essential oils.
Instrumental skin measuresWDTE60N: 250 mg of product daily, containing 150 mg of a curcuminoid mixture, for 60 days.

A randomized, placebo-controlled, crossover clinical trial to evaluate the effect of a turmeric formulation on muscle soreness and function recovery in moderately active adults ↗
Efficacy of a curcumin extract (Curcugen) on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomised, double-blind, placebo-controlled study ↗
Efficacy and Safety of an Oral Low-Dose Water-Dispersible Turmeric Extract Capsule on Facial Skin Health in Healthy Women: A Randomized, Double-Blind, Placebo-Controlled Trial ↗

Forms

Curcuminoids are a mixture of curcumin, demethoxycurcumin and bisdemethoxycurcumin in proportions that depend on the product. Extract mass, mixture mass and the mass of an individual molecule differ; delivery system properties are not interchangeable.

Guidance for each goal

Area under the soreness curve1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: Small samples, wide intervals, multiple outcomes or unclear clinical significance. Consistency of results: Differences in results and compositions, or unknown reproducibility in a single trial. Applicability to the stated group: The formulation, clinical population or surrogate limits extrapolation to the entire class of mixtures and healthy people. Possible publication bias: Insufficient data for a separate downgrade; absence of bias has not been demonstrated. Study methods: Limitations of small trials, selective measurement, missing data or incomplete independent verification of the protocol.

After unfamiliar downhill running, no clear difference in total soreness over 72 hours was found.

Study findings. After unfamiliar downhill running, no clear difference in total soreness over 72 hours was found.

Studied regimen300 mg of product, 90 mg of curcuminoidsColloidal curcuminoid mixture
Duration and population5 days, follow-up 72 hours44 moderately active adults

Comparison with Placebo

Overall GSRS2/4 LowRead moreCollapse
Confidence
2/4 LowPrecision of the estimate: The CI of the difference was not extracted. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: The measurement directly addresses the specified narrow PICO. Possible publication bias: No specific data for a separate downgrade. Study methods: One small sponsored trial, 77 of 79 provided data.

Over 8 weeks, Curcugen reduced the overall digestive symptom score more than placebo.

Study findings. Over 8 weeks, Curcugen reduced the overall digestive symptom score more than placebo.

Studied regimen500 mg of extract/day, approximately 250 mg of curcuminoidsCurcugen, a standardized turmeric extract with 50% curcuminoids and 1.5% essential oils
Duration and population8 weeks79 adults with self-reported gastrointestinal complaints, 77 included in the self-report analysis

Comparison with Placebo

MoistureMeterSC hydration1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: Uncertain effect size for this outcome. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: An instrumental measure; consumer relevance has not been established. Possible publication bias: No specific data for a separate downgrade. Study methods: Many outcomes, a sponsor and completer analysis.

In the WDTE60N study, the instrumental skin hydration measure increased compared with placebo.

Study findings. In the WDTE60N study, the instrumental skin hydration measure increased compared with placebo.

Studied regimen250 mg of product/day, 150 mg of a curcuminoid mixtureWDTE60N, a water-dispersible extract with 60% natural curcuminoids
Duration and population60 days96 healthy women aged 18–40 randomized, 90 completed

Comparison with Placebo

Spot intensity1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: Uncertain effect size for this outcome. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: An instrumental measure; consumer relevance has not been established. Possible publication bias: No specific data for a separate downgrade. Study methods: Many outcomes, a sponsor and completer analysis.

In the WDTE60N study, the instrumental spot intensity measure decreased by 2.28% versus 0.31% with placebo.

Study findings. In the WDTE60N study, the instrumental spot intensity measure decreased by 2.28% versus 0.31% with placebo.

Studied regimen250 mg of product/day, 150 mg of a curcuminoid mixtureWDTE60N, a water-dispersible extract with 60% natural curcuminoids
Duration and population60 days96 healthy women aged 18–40 randomized, 90 completed

Comparison with Placebo

Transepidermal water loss1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: No confidence interval is given for the between-group difference. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: An extract containing a curcuminoid mixture. Possible publication bias: No specific data for a separate downgrade. Study methods: Multiple measures and time points.

In this trial, the WDTE60N mixture reduced measured water loss from the skin compared with placebo.

Study findings. In this trial, the WDTE60N mixture reduced measured water loss from the skin compared with placebo.

Studied regimen250 mg of product/day, 150 mg of a curcuminoid mixtureWDTE60N, a water-dispersible extract with 60% natural curcuminoids
Duration and population60 days96 healthy women aged 18–40 randomized, 90 completed

Comparison with placebo

Instrumental gloss1/4 Very lowRead moreCollapse
Confidence
1/4 Very lowPrecision of the estimate: No confidence interval is given for the between-group difference. Consistency of results: No grounds for a separate downgrade. Applicability to the stated group: An extract containing a curcuminoid mixture. Possible publication bias: No specific data for a separate downgrade. Study methods: Multiple measures and time points.

In this trial, the WDTE60N mixture increased the instrumental skin gloss measure compared with placebo.

Study findings. In this trial, the WDTE60N mixture increased the instrumental skin gloss measure compared with placebo.

Studied regimen250 mg of product/day, 150 mg of a curcuminoid mixtureWDTE60N, a water-dispersible extract with 60% natural curcuminoids
Duration and population60 days96 healthy women aged 18–40 randomized, 90 completed

Comparison with placebo

Safety and limitations

DILIN: 10 cases of liver injury associated with turmeric products, 5 hospitalizations and one death; neither the consumer denominator nor the responsible component was identified. Improvement in average enzyme levels does not rule out rare severe harm. 60 healthy adults; Turmipure Gold 1000 mg of product (>30% curcuminoids) versus placebo for 5 weeks; any events 22/30 versus 18/30, causality of individual events unknown. The safety of concentrated supplements during pregnancy has not been established; food amounts are not equivalent to supplement doses. Data on high doses and infant exposure are insufficient; a study of a fenugreek, ginger and turmeric mixture does not isolate curcuminoids. Short studies in individual clinical groups do not establish universal long-term safety in children. If marked fatigue, nausea, loss of appetite, dark urine or jaundice develops while taking a turmeric or curcumin supplement, stop taking it and seek medical advice. The risk of liver injury may be higher with high-dose supplements or those with enhanced absorption. People with current or previous liver disease should avoid turmeric or curcumin supplements. Nausea, vomiting, reflux, abdominal discomfort, diarrhoea and constipation may occur. Before surgery, tell the surgical team that you take a turmeric or curcumin supplement.

Liver Injury Associated with Turmeric-A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network ↗ · Safety assessment and gastrointestinal tolerance of a novel highly bioavailable turmeric extract formulation: A randomised, double-blind, placebo controlled clinical trial ↗ · Turmeric: Usefulness and Safety ↗ · Turmeric - Drugs and Lactation Database (LactMed) ↗ · Curcumin in children with autism spectrum disorder: systemic inflammation, sensory regulation, and gut-brain interaction disorders. A randomized, double-blind, placebo-controlled clinical trial (CURATEA) ↗ · TGA Medicines containing turmeric or curcumin - risk of liver injury ↗ · Herbal remedies and dietary supplements - Overview | Guy's and St Thomas' NHS Foundation Trust ↗

Interactions

WithEffectActionSource
MidazolamIn 8 healthy adults, a mixture of 4 g of curcuminoids and 24 mg of piperine per dose, four times over two days, showed no significant change in the AUC of oral midazolam 3 mg compared with midazolam after placebo: ratio 0.91 (90% CI 0.75–1.11). This does not prove the absence of interactions with other regimens.Discuss supplement use with the doctor who prescribed the medicine.Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol pharmacokinetics in healthy volunteers ↗
WarfarinAfter adding a turmeric product in one person receiving stable treatment, an INR above 10 was reported; one case does not determine the frequency of the reaction.Before using the supplement, discuss it and INR monitoring with your doctor.Turmeric/Curcumin interaction with warfarin - Medsafe safety communication ↗
TamoxifenIn a crossover study, curcumin with piperine reduced endoxifen AUC by 12.4%; without piperine, the change was −7.7%, with an interval including no difference. Clinical outcomes were not measured.Before using the supplement, discuss it with your treating oncologist.Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen ↗
Other anticoagulants and antiplatelet medicinesMedsafe warns of potentially increased bleeding when turmeric or curcumin supplements are combined with these medicines.Before using the supplement, discuss it with the doctor who prescribed these medicines.Turmeric/Curcumin interaction with warfarin - Medsafe safety communication ↗

Food sources

The composition of a curcuminoid mixture depends on the product; the amount of one component does not determine the amount of the entire mixture.

Turmeric used as a spice contains a mixture of curcuminoids, including curcumin. The amount in a dish is not equated with the dose of a standardized extract.

Turmeric: Usefulness and Safety ↗

In a study of 13 commercial powders, the mass fraction of one component, curcumin, was 0.057–2.06%. This is a measurement of an individual substance, not total curcuminoids.

Chromatographic evaluation of curcumin content in commercial samples ↗

Ground turmeric Ground turmeric rhizome contains a curcuminoid mixture, including curcumin.

Turmeric: Usefulness and Safety ↗
Chromatographic evaluation of curcumin content in commercial samples ↗

Rhizome and dishes Turmeric rhizome is used in cooking; the composition of a portion depends on the specific product and recipe.

Turmeric: Usefulness and Safety ↗
Turmeric | Memorial Sloan Kettering Cancer Center ↗

Spice blends Turmeric is an ingredient in curry powder.

Turmeric | Memorial Sloan Kettering Cancer Center ↗

Studies

PublicationWhat was studiedParticipantsForm and doseResult
A randomized, placebo-controlled, crossover clinical trial to evaluate the effect of a turmeric formulation on muscle soreness and function recovery in moderately active adults ↗randomized controlled trialArea under the soreness curve44 moderately active adultsColloidal curcuminoid mixture; 300 mg of product, 90 mg of curcuminoids; 5 days, follow-up 72 hours; comparison: PlaceboAfter unfamiliar downhill running, no clear difference in total soreness over 72 hours was found.
Efficacy of a curcumin extract (Curcugen) on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomised, double-blind, placebo-controlled study ↗randomized controlled trialOverall GSRS79 adults with self-reported gastrointestinal complaints, 77 included in the self-report analysisCurcugen, a standardized turmeric extract with 50% curcuminoids and 1.5% essential oils; 500 mg of extract/day, approximately 250 mg of curcuminoids; 8 weeks; comparison: PlaceboOver 8 weeks, Curcugen reduced the overall digestive symptom score more than placebo.

Sources

Sources
  1. A randomized, placebo-controlled, crossover clinical trial to evaluate the effect of a turmeric formulation on muscle soreness and function recovery in moderately active adults ↗
  2. Efficacy of a curcumin extract (Curcugen) on gastrointestinal symptoms and intestinal microbiota in adults with self-reported digestive complaints: a randomised, double-blind, placebo-controlled study ↗
  3. Efficacy and Safety of an Oral Low-Dose Water-Dispersible Turmeric Extract Capsule on Facial Skin Health in Healthy Women: A Randomized, Double-Blind, Placebo-Controlled Trial ↗
  4. Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol pharmacokinetics in healthy volunteers ↗
  5. Oil-Based Curcuminoid Phospholipid Formulation Mimicking Natural Digestion Enhances Oral Bioavailability of Curcuminoids in Healthy Subjects ↗
  6. Liver Injury Associated with Turmeric-A Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network ↗
  7. Safety assessment and gastrointestinal tolerance of a novel highly bioavailable turmeric extract formulation: A randomised, double-blind, placebo controlled clinical trial ↗
  8. Turmeric/Curcumin interaction with warfarin - Medsafe safety communication ↗
  9. Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen ↗
  10. Turmeric: Usefulness and Safety ↗
  11. Turmeric - Drugs and Lactation Database (LactMed) ↗
  12. Curcumin in children with autism spectrum disorder: systemic inflammation, sensory regulation, and gut-brain interaction disorders. A randomized, double-blind, placebo-controlled clinical trial (CURATEA) ↗
  13. Comparison of Label Claims, Measured Curcuminoid Content and Dosage Form Performance Quality With Industry Standards for Turmeric Dietary Supplements ↗
  14. Chromatographic evaluation of curcumin content in commercial samples ↗
  15. Turmeric | Memorial Sloan Kettering Cancer Center ↗
  16. TGA Medicines containing turmeric or curcumin - risk of liver injury ↗
  17. Herbal remedies and dietary supplements - Overview | Guy's and St Thomas' NHS Foundation Trust ↗